Dopamine (DA) release in the striatum is regulated by 5-hydroxytryptamine (5-HT, serotonin) through putative heteroreceptors. However, the effect of 5-HT is controversial. The present study investigated the effects of different 5-HT receptor ligands on DA release in the rat striatum by using in vivo
L-Tryptophan and prolactin release: Evidence for interaction between 5-HT1 and 5-HT2 receptors
β Scribed by E. M. Charig; I. M. Anderson; J. M. Robinson Sen; D. J. Nutt; P. J. Cowen
- Publisher
- John Wiley and Sons
- Year
- 1986
- Tongue
- English
- Weight
- 429 KB
- Volume
- 1
- Category
- Article
- ISSN
- 0885-6222
No coin nor oath required. For personal study only.
β¦ Synopsis
The effects of the selective 5-HT2 receptor antagonist, ritanserin, on the growth hormone (GH) and prolactin (PRL) responses to intravenous L-tryptophan (LTP) were assessed in 8 normal volunteers. Administration of ritanserin (40 mg orally) prior to infusion of LTP (5 g) significantly enhanced the PRL responses but not those of GH. The results are consistent with previous proposals that the endocrine responses to LTP are mediated by 5-HT1 rather than 5-HT2 receptors and also suggest that 5-HT2 receptor antagonists may increase certain 5-HT, mediated responses in the human brain.
π SIMILAR VOLUMES
## Abstract Activation of Ξ³βaminobutyric acid B (GABA~B~) and 5βhydroxytryptamine (5βHT) receptors produces presynaptic inhibition at glutamatergic terminals in the rat neocortex. To evaluate interactions between these metabotropic receptors, field potentials were recorded in layer 2/3 of somatosen
The authors mistakenly stated that all records were done in ''somato-sensory cortex'' when in fact some of the records in the report were actually done in motor cortex. Thus, ''somato-sensory cortex'' should be replaced by ''sensory-motor cortex'' throughout the piece. The authors regret this mistak